TCL Archive Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study November 26, 2010
TCL Archive Clinical Trials: Oncologists, Insurance Executive, Comment On The Results Of Transplant Trials May 28, 1999
TCL Archive Cancer Genetics: risk from Three BRCA Mutations Lower Than Expected, NCI Finds May 23, 1997